apomorphine has been researched along with curcumin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Dargusch, R; Maher, PA; Schubert, D; Valera, E | 1 |
| da Silva Neto, MR; de Gomes, MG; de Oliveira Pacheco, C; Dos Santos, RB; Giacomeli, R; Haas, SE; Maciel, TR; Parisotto, AJM; Ribeiro, ACF | 1 |
| Mohajeri, D; Nourazar, MA; Sokouti, H | 1 |
3 other study(ies) available for apomorphine and curcumin
| Article | Year |
|---|---|
Modulation of 5-lipoxygenase in proteotoxicity and Alzheimer's disease.
Topics: Activating Transcription Factor 4; Alzheimer Disease; Amyloid beta-Peptides; Animals; Apomorphine; Arachidonate 5-Lipoxygenase; Behavior, Animal; Blotting, Western; Curcumin; Dopamine Agonists; Electrophoresis, Polyacrylamide Gel; Eukaryotic Initiation Factor-2; Humans; Lipoxygenase Inhibitors; Maze Learning; Mice; Mice, Transgenic; Peptide Fragments; Phosphorylation; Proteasome Endopeptidase Complex; Protein Folding; Pyrazoles; RNA, Messenger; Ubiquitin | 2013 |
Surface-functionalized curcumin-loaded polymeric nanocapsules could block apomorphine-induced behavioral changes in rats.
Topics: Animals; Apomorphine; Behavior, Animal; Curcumin; Dopamine Agonists; Enzyme Inhibitors; Hexoses; Nanocapsules; Plants, Medicinal; Rats; Stereotyped Behavior; Treatment Outcome; Vitamin E | 2022 |
6-Hydroxydopamine-Induced Neurotoxicity in Rat Model of Parkinson's Disease: Is Reversed via Anti-Oxidative Activities of Curcumin and Aerobic Exercise Therapy.
Topics: alpha-Synuclein; Animals; Antioxidants; Apomorphine; Curcumin; Disease Models, Animal; Glutathione Peroxidase; Malondialdehyde; Neuroprotective Agents; Neurotoxicity Syndromes; Neurotoxins; Oxidopamine; Parkinson Disease; Rats; Substantia Nigra | 2022 |